期刊文献+

重组抗HER2 ScFv/tBid基因的表达对SGC7901胃癌细胞的促凋亡作用

Investigation of Apoptosis of the SGC7901 Cells Induced by the Expression of the Recombinant Gene of anti-HER2 ScFv/tBid
下载PDF
导出
摘要 目的:构建重组抗HER2 ScFv/tBid载体并观察其对胃癌SGC7901细胞的促凋亡作用。方法:将重组抗HER2 ScFv/tBid基因克隆入真核表达载体pCMV中,转染SGC7901细胞,用RT- PCR方法检测目的基因在mRNA水平的表达,间接免疫荧光法检测目的蛋白表达和细胞形态学变化,通过细胞计数检测转染目的基因后对细胞生长的影响,通过检测细胞周期来观察其促凋亡作用。结果:转染SGC7901细胞后,检测出目的蛋白的表达。细胞计数发现细胞的增殖被明显抑制。细胞周期分析有明显的凋亡峰出现,说明重组抗HER2 ScFv/tBid表达后有促凋亡作用。结论:重组抗HER2 ScFv/tBid基因可以在转染的SGC7901细胞中表达,并且可抑制转染细胞的生长,诱导细胞发生凋亡。 Objetive : To investigate whether apoptosis of SGC7901 cells can be induced by the expression of the recombinant gene of anti-HER2 ScFv/tBid. Methods: The recombinant anti-HER2 ScFv/tBid gene was cloned into vector pCMV and the recombinant plasmid was transfected into SGC7901 cells. The gene expression was detected by RT-PCR and immunofluorescent staining. Cell counting was carried out to show the effect of the gene transfection on cell growth. At the same time, significant apoptotic peak was detected by flow cytometry in recombinant anti-HER2 ScFv/tBid gene transfected ceils. Results: The fusion protein of anti-HER2 ScFv/tBid was observed in the cytoplasm of transfected SGC7901 ceils. The transfected ceils displayed typical cell growth inhibition and apoptosis. Conclusion : Fusion protein of anti-HER2 ScFv/tBid can induce apoptosis of SGC7901.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2006年第4期1-6,共6页 China Biotechnology
基金 国家"863"计划资助项目(2004AA217071) 国家"973"计划资助项目(2004CB518805) 教育部"长江学者和创新团队发展计划"资助项目(IRT0459) 国家自然科学基金资助项目(30370314)
关键词 重组抗HER2 ScFv/tBid分子SGC7901胃癌细胞细胞凋亡 Fusion protein of anti-HER2 ScFv/tBid SGC7901 cell Apoptosis
  • 相关文献

参考文献13

  • 1Korsmeyer S J,Wei M C,Saito M,et al.Pro-apoptotic cascade activates BID,which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.Cell Death Differ,2000,7:1166~1173
  • 2Degli Esposti M.The roles of Bid.Apoptosis,2002,7:433 ~440
  • 3Wei M C,Lindsten T,Mootha V K.tBID,a membrane-targeted death ligand,oligomerizes BAK to release cytochrome c.Genes Dev,2000,14:2060~2071
  • 4Baxevanis C N,et al.Immunobiology of HER2/neu oncoprotein and its potential application in cancer immunotherapy.Cancer Immunol Immunother,2004,53:166 ~ 175
  • 5Salmon D J,Clark G M,Wong S G,et al.Human breast cancer:correlation of relapse and survival with amplification of the HER2/neu oncogene.Science,1987,235:177 ~ 182
  • 6Brog A,Tandon A K,Sigurfaaon H,et al.HER2/neu amplification predicts poor survival in node-positive breast cancer.Cancer Res,1990,50:4332 ~4337
  • 7Feng Bi,Daiming Fan,Hongxiang Hui,et al.Reversion of the maliganant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme.Cancer Gene Ther,2001,8(11):835 ~842
  • 8Xu Y M,Wang L F,Jia L T,et al.A caspase-6 and antihuman epidermal growth factor receptor-2 (HER2) antibody chimeric molecule suppresses the growth of HER2-overexpressing tumors.J Immunol,2004,173(1):61 ~67
  • 9裘秀春,于翠娟,许彦鸣,贾林涛,曹云新,王智,王成济,范清宇,杨安钢.截短型人Bid融合蛋白对HeLa细胞的促凋亡作用[J].第四军医大学学报,2003,24(21):1963-1966. 被引量:8
  • 10裘秀春,于翠娟,孟艳玲,许彦鸣,赵晶,金明,王成济,范清宇,杨安钢.截短型人bid基因的克隆、表达和促凋亡作用的研究[J].细胞与分子免疫学杂志,2004,20(1):19-22. 被引量:6

二级参考文献5

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部